5 Results for "

MS8847

" in MedChemExpress (MCE) Product Catalog:
Products (5)

5 Results for "MS8847" in MCE Product Catalog:

Cat. No.: HY-162250
CAS No.: 3050872-59-5
Research Areas:  

Cancer

MS8847 is a PROTAC degrader and antiproliferative agent targeting EZH2 (DC50=34.4 nM in EOL-1 MLL-rAML cells). MS8847 recruits the E3 ligase von Hippel-Lindau (VHL) to mediate the degradation of EZH2 via the ubiquitin-proteasome system. MS8847 induces antiproliferative effects in MLL-rearranged acute myeloid leukemia cells and inhibits the growth of triple-negative breast cancer cell lines or 3D triple-negative breast cancer models. MS8847 is applicable to research related to MLL-rearranged acute myeloid leukemia and triple-negative breast cancer .
loading...
    loading...
Cat. No.: HY-186269
CAS No.: 3050872-76-6
Target:  

PROTACs

Research Areas:  

Cancer

MS8847N1 is a negative control analog of MS8847 (HY-162250), which abolishes binding to EZH2 while retaining the activity of recruiting VHL. MS8847N1 does not induce EZH2 degradation. MS8847N1 can be used in PROTAC-related research .
loading...
    loading...
Cat. No.: HY-185582
CAS No.: 3050872-19-7
EZH2 ligand-4 (Precursor 1) is a ligand for the target protein for PROTAC (EZH2). EZH2 ligand-4 can be used to synthesize MS8847 (HY-162250) .
loading...
    loading...
Cat. No.: HY-186272
CAS No.: 3050872-64-2
Research Areas:  

Others

MS8847N2 is a negative control analog of an EZH2 PROTAC degrader that binds EZH2 but does not bind the VHL E3 ligase or induce EZH2 degradation .
loading...
    loading...
Cat. No.: HY-186270
CAS No.: 3050872-68-6
Research Areas:  

Others

CBP/BRD4-IN-1 (Compound 22) is a dual bromodomain inhibitor of CBP and BRD4 BD1, with IC50 values of 1.2 μM and 3.2 μM, respectively. CBP/BRD4-IN-1 serves as a target protein ligand for the synthesis of PROTACs, such as MS8847N1 (HY-18626) .
loading...
    loading...